| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Acurx Pharmaceuticals (NASDAQ:ACXP) will release its quarterly earnings report on Tuesday, 2025-08-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Acurx Pharmaceuticals to report an earnings per share (EPS) of $-2.06.
The market awaits Acurx Pharmaceuticals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
The company's EPS beat by $0.18 in the last quarter, leading to a 3.24% drop in the share price on the following day.
Here's a look at Acurx Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.18 | -0.20 | -0.22 |
| EPS Actual | -0.11 | -0.17 | -0.17 | -0.26 |
| Price Change % | -3.0% | 3.0% | -2.0% | -1.0% |
Shares of Acurx Pharmaceuticals were trading at $4.47 as of August 08. Over the last 52-week period, shares are down 88.28%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Acurx Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ACXP
